Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Outset Medical Inc

OM
Current price
0.77 USD -0.023 USD (-2.91%)
Last closed 0.78 USD
ISIN US6901451079
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 31 774 778 USD
Yield for 12 month -78.81 %
1Y
3Y
5Y
10Y
15Y
OM
21.11.2021 - 28.11.2021

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.15 USD

P/E ratio

Dividend Yield

Current Year

+130 376 000 USD

Last Year

+115 375 000 USD

Current Quarter

+27 388 000 USD

Last Quarter

+28 168 000 USD

Current Year

+29 000 000 USD

Last Year

+17 833 000 USD

Current Quarter

+9 782 000 USD

Last Quarter

+8 215 000 USD

Key Figures OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -144 640 000 USD
Operating Margin TTM -112.33 %
PE Ratio
Return On Assets TTM -28.99 %
PEG Ratio
Return On Equity TTM -126.48 %
Wall Street Target Price 3.15 USD
Revenue TTM 116 425 000 USD
Book Value 1.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -24 %
Dividend Yield
Gross Profit TTM 17 833 000 USD
Earnings per share -3.14 USD
Diluted Eps TTM -3.14 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -136.72 %

Dividend Analytics OM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.337
Price Sales TTM 0.2729
Enterprise Value EBITDA -0.2367
Price Book MRQ 0.4632

Financials OM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OM

For 52 weeks

0.44 USD 6.37 USD
50 Day MA 0.57 USD
Shares Short Prior Month 3 473 477
200 Day MA 2.47 USD
Short Ratio 3.83
Shares Short 3 470 550
Short Percent 7.8 %